Veterinary Molecular Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Veterinary Molecular Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • March 2022 •
  • 147 pages •
  • Report ID: 6246964 •
  • Format: PDF
The global veterinary molecular diagnostics market reached a value of US$ 581.4 Million in 2021. Looking forward, the analyst expects the market to reach a value of US$ 1,064.1 Million by 2027 exhibiting a CAGR of 9.40% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Veterinary molecular diagnostics assist clinicians in detecting, identifying, and genotyping a broad range of viral, bacterial, and vector-borne pathogens among animals using molecular-based methods, such as conventional and quantitative polymerase chain reaction (PCR). They require small amounts of a diverse spectrum of biological sample types, which further allow rapid and highly sensitive detection of nucleic acids and diagnosis of infectious diseases. At present, an array of molecular techniques of different complexity are used in veterinary health centers and research laboratories to facilitate the fast and specific diagnosis of animal diseases.

Veterinary Molecular Diagnostics Market Trends:
The escalating number of animal husbandry activities, along with the rising concerns about food safety, represents one of the major factors catalyzing the demand for veterinary molecular diagnostics for better diagnosis and treatment of livestock. Additionally, the outbreak of coronavirus disease (COVID-19) across the globe is driving the need for PCR testing to analyze the effect of the infection in animals. Apart from this, the increasing pet ownership on account of the emerging nuclear family trends and inflating income levels, coupled with the rising pet humanization, is bolstering the market growth. This can also be attributed to the increasing uptake of pet insurance policies due to the growing concerns among pet parents about the well-being of their pets. Moreover, governing agencies of numerous countries are supporting veterinary practices and commercial animal-production programs, which, in turn, is strengthening the adoption of veterinary molecular diagnostics around the world. Besides this, the introduction of advanced genotyping techniques, such as whole-genome sequencing (WGS), in confluence with the surging demand for customized reagents and kits, is anticipated to influence the market positively.

Key Market Segmentation:
the analyst provides an analysis of the key trends in each sub-segment of the global veterinary molecular diagnostics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, technology, animal type, disease type and end user.

Breakup by Product:
Kits and Reagents
Software and Services

Breakup by Technology:
Real Time PCR
DNA Sequencing

Breakup by Animal Type:
Companion Animal
Livestock Animal

Breakup by Disease Type:
Vector-borne Diseases
Respiratory Pathogens
Diarrhea Pathogens

Breakup by End User:
Veterinary Hospitals
Clinical Laboratories
Research Institutes

Breakup by Region:
North America
United States
South Korea
United Kingdom
Latin America
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Biochek B.V., bioMérieux SA, HealthGene Corporation, Heska Corporation, IDEXX Laboratories Inc., INDICAL BIOSCIENCE GmbH, Ingenetix GmbH, NEOGEN Corporation, Qiagen N.V, Thermo Fisher Scientific Inc., Veterinary Molecular Diagnostics Inc. and Zoetis Inc.

Key Questions Answered in This Report:
How has the global veterinary molecular diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global veterinary molecular diagnostics market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the animal type?
What is the breakup of the market based on the disease type?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global veterinary molecular diagnostics market and who are the key players?
What is the degree of competition in the industry?